MedeAnalytics Promotes the Importance of Early Breast Cancer Detection
In October, MedeAnalytics is recognizing Breast Cancer Awareness Month, a worldwide campaign to increase awareness, education and research about breast health and the importance of early detection. Breast cancer is the second most common kind of cancer in women, and one in eight women will get breast cancer in their life time. Through annual screenings like mammograms, women can survive breast cancer when it’s found and treated early.
Here’s how MedeAnalytics will recognize Breast Cancer Awareness Month:
- Our associates will be participating as a team, Mede Pirates of The Cure-Ribbean, in the Race for the Cure in Dallas on Saturday, October 26 and remote employees will be joining their local races.
- MedeAnalytics has partnered with Susan G. Komen to present a collaborative Lunch & Learn educational event hosted by Susan G. Komen ambassador Natasha Mmeje. MedeAnalytics’ employees will learn about the latest in breast cancer research and treatment resources.
- Wear Pink Wednesdays will be acknowledged throughout October to drive awareness
- Employees can share their personal stories of their loved ones and friends to show support on our internal message board
Join us as we participate in promoting this important message of hope and support.
Get our take on industry trends
How to help employer groups plan in a time of uncertainty
Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”
Read on...
Healthcare’s return to “normal” after COVID-19: Is it possible?
As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”
Read on...
Avoid COVID-19 modeling pitfalls by eliminating bias, using good data
COVID-19 models are being used every day to predict the course and short- and long-term impacts of the pandemic. And we’ll be using these COVID-19 models for months to come.
Read on...
Population Health Amid the Coronavirus Outbreak
In speaking with many colleagues throughout the provider and payer healthcare community, I’ve found an overwhelming sense of helplessness to the outbreak’s onslaught. This is exacerbated by the constant evolution of reported underlying medical conditions that indicate a higher risk of hospitalization or mortality for a coronavirus patient.
Read on...